| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate |
2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6fdcf48483be336046a164f5bf4c1cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b7200bf3db6f16b78a4e36cdb02394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809f9d7ca331206051b382f37d887de6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22bd4627343b6bc3dfecbc64a0483b73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c3b5925bf37ea8e968ca6df46306e32 |
| publicationDate |
2018-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018280522-A1 |
| titleOfInvention |
Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use |
| abstract |
The invention relates to novel derivatives of thapsigargin that are chemically modified with a group that targets a cell surface-expressed receptor, and pharmaceutical preparations thereof. The invention further relates to methods of treating diseases such as cancer using the compounds of the invention. |
| priorityDate |
2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |